Previous Close | 25.07 |
Open | 25.04 |
Bid | 23.28 x 0 |
Ask | 25.73 x 0 |
Day's Range | 24.52 - 25.25 |
52 Week Range | 15.95 - 28.09 |
Volume | |
Avg. Volume | 943,560 |
Market Cap | 24.773B |
Beta (5Y Monthly) | 0.80 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.09 |
Earnings Date | Jul 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 11, 2023 |
1y Target Est | N/A |
Philips MR 5300 BlueSeal installation at Vida Imaging & Breast Center, Bayamon, Puerto Rico Exterior picture of Vida Imaging & Breast Center, Bayamon, Puerto Rico A clinician using a Philips MR 5300 May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI ope
Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.